17-JUN-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1158 16 835 83 1011 190 1157
ERLYTX 82 1 52 10 122 17 103
GI 174 5 261 16 195 33 201
GU 348 7 365 35 426 55 335
LEUK 160 8 417 23 280 37 225
LUNG 199 4 209 22 268 30 183
LYMPH 409 8 417 44 536 91 554
MELAN 91 0 0 0 0 0 0
MMYEL 119 2 104 14 170 21 128
MULT 46 2 104 6 73 10 61
OTHER 55 0 0 2 24 5 30
SXQOL 3 2 104 2 24 2 12
Total 2844 55 2868 257 3129 491 2989

17-JUN-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 166 5 261 16 195 35 213
ERLYTX 8 1 52 1 12 2 12
GU 4 0 0 0 0 1 6
LEUK 624 3 157 52 633 104 633
LUNG 373 2 104 26 317 47 286
OTHER 33 0 0 0 0 3 18
PEOLC 102 0 0 2 24 3 18
PREV 242 5 261 30 365 50 304
SXQOL 615 9 470 48 584 107 651
Total 2167 25 1305 175 2130 352 2141

17-JUN-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1158 16 835 83 1011 190 1157
CCD 166 5 261 16 195 35 213
ERLYTX 90 2 104 11 134 19 116
GI 174 5 261 16 195 33 201
GU 352 7 365 35 426 56 341
LEUK 784 11 574 75 913 141 858
LUNG 572 6 313 48 584 77 469
LYMPH 409 8 417 44 536 91 554
MELAN 91 0 0 0 0 0 0
MMYEL 119 2 104 14 170 21 128
MULT 46 2 104 6 73 10 61
OTHER 88 0 0 2 24 8 49
PEOLC 102 0 0 2 24 3 18
PREV 242 5 261 30 365 50 304
SXQOL 618 11 574 50 609 109 664
Total 5011 80 4173 432 5259 843 5133

17-JUN-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 722 10 522 44 536 111 676
ERLYTX 50 0 0 7 85 13 79
GI 126 4 209 10 122 23 140
GU 274 5 261 25 304 44 268
LEUK 101 4 209 13 158 21 128
LUNG 127 1 52 15 183 22 134
LYMPH 266 5 261 32 390 62 377
MELAN 61 0 0 0 0 0 0
MMYEL 68 0 0 6 73 7 43
MULT 17 0 0 2 24 2 12
OTHER 55 0 0 2 24 5 30
SXQOL 3 2 104 2 24 2 12
Total 1870 31 1618 158 1923 312 1899

17-JUN-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 131 4 209 11 134 23 140
ERLYTX 8 1 52 1 12 2 12
GU 4 0 0 0 0 1 6
LEUK 276 0 0 28 341 47 286
LUNG 229 0 0 13 158 26 158
OTHER 33 0 0 0 0 3 18
PEOLC 77 0 0 2 24 3 18
PREV 240 3 157 28 341 48 292
SXQOL 441 5 261 30 365 74 450
Total 1439 13 679 113 1375 227 1380

17-JUN-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 894 11 574 58 706 140 852
CCD 159 3 157 10 122 25 152
ERLYTX 58 1 52 8 97 15 91
GI 129 2 104 9 110 19 116
GU 308 5 261 28 341 47 286
LEUK 378 4 209 41 499 68 414
LUNG 375 1 52 28 341 51 310
LYMPH 266 5 261 32 390 62 377
MELAN 61 0 0 0 0 0 0
MMYEL 68 0 0 6 73 7 43
MULT 41 0 0 5 61 6 37
OTHER 199 0 0 2 24 8 49
PEOLC 77 1 52 5 61 6 37
PREV 240 3 157 28 341 48 292
SXQOL 444 7 365 32 390 76 463
Total 3697 43 2244 292 3556 578 3519

17-JUN-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 971 14 730 77 937 165 1004
ERLYTX 77 1 52 10 122 17 103
GI 103 2 104 10 122 19 116
GU 239 5 261 28 341 44 268
LEUK 126 7 365 21 256 34 207
LUNG 171 4 209 20 244 27 164
LYMPH 342 6 313 38 463 80 487
MMYEL 103 2 104 12 146 18 110
MULT 46 2 104 6 73 10 61
Total 2178 43 2242 222 2704 414 2520

17-JUN-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
Member 1959 24 1252 163 1985 316 1924
AFFIL 141 2 104 15 183 28 170
CCOP/NCORP 1209 18 939 93 1132 195 1187
Non-SWOG 1696 30 1565 155 1887 298 1814
Total 5005 74 3860 426 5187 837 5095

17-JUN-2026 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
CCD S2424CD A-PACT vs SOC for GOC communication 1 Y 01-JUN-26
LEUK S2504 Richter Trans., Untreated, R-CHOP +/- Pirto 1 Y 01-JUN-26

17-JUN-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
GU EA8134 Penile, Local Adv, ILND +/- Chemo or ChemoRT 1 E 29-MAY-26
GU EA8134 Penile, Local Adv, ILND +/- Chemo or ChemoRT 2 E 29-MAY-26
ERLYTX SN2426 cSCC, IC Met/Inop, Amivantamab v Cetuximab 1 T 22-MAY-26
SXQOL ACCL1931 Leuk, All Stg, Levocarnitine Prophylaxis 1 E 22-MAY-26
SXQOL ACCL1931 Leuk, All Stg, Levocarnitine Prophylaxis 2 E 22-MAY-26
CCD EAQ221CD Breast, Metastatic, Imp. Adherence 0 E 05-JUN-26
CCD EAQ221CD Breast, Metastatic, Imp. Adherence 1 E 05-JUN-26
MELAN A091903 Melan, Resected Mucosal, Adj Nivo +/- Cabo 0 E 04-JUN-26
MELAN A091903 Melan, Resected Mucosal, Adj Nivo +/- Cabo 1 E 04-JUN-26

17-JUN-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 12
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 7
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 5
LEUK S1925 CLL/SLL, Newly Dx HR, Early vs Delayed V+O 1 4
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 4
CCD S2417CD Colrec Surv, Follow-up w/ CTAC site 1 4
PREV A212102 Blind Ref Set for Multicancer Early Detection 1 3
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 3
GU S1802 Pros, Stg IV, SST ± Surg/RT to Primary Tum 1 3